Matthew Ros
2017
In 2017, Matthew Ros earned a total compensation of $1.5M as Chief Operating Officer at Epizyme, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $159,300 |
|---|---|
| Option Awards | $899,627 |
| Salary | $391,400 |
| Other | $2,066 |
| Total | $1,452,393 |
Ros received $899.6K in option awards, accounting for 62% of the total pay in 2017.
Ros also received $159.3K in bonus, $391.4K in salary and $2.1K in other compensation.
Rankings
In 2017, Matthew Ros' compensation ranked 7,158th out of 14,666 executives tracked by ExecPay. In other words, Ros earned more than 51.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,158 out of 14,666 | 51st |
Division Manufacturing | 2,664 out of 5,772 | 54th |
Major group Chemicals And Allied Products | 871 out of 2,075 | 58th |
Industry group Drugs | 680 out of 1,731 | 61st |
Industry Pharmaceutical Preparations | 533 out of 1,333 | 60th |
Source: SEC filing on April 5, 2018.
Ros' colleagues
We found three more compensation records of executives who worked with Matthew Ros at Epizyme in 2017.